Trial
NCT05926206
Trial of Devimistat in Combination With Modified FOLFIRINOX in Patients With Metastatic Adenocarcinoma of the Pancreas
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Michigan Rogel Cancer Center
Collaborators
—
Condition
Metastatic Pancreatic Adenocarcinoma
Intervention
Devimistat
Why stopped
based some additional data, we have decided to hold off this trial for now and will not be proceeding with this particular trial
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-08-02